Contract Research Organization WCCT Global’s CEO Dr. Kenneth Kim to Speak at the 2013 Up-to-date Topics in Global Clinical Trials Conference in Korea

December 5, 2013

CEO of Contract Research Organization WCCT Global is scheduled to speak in Korea on what is trending in the clinical trial arena and how CROs are conducting research in new innovative ways.

Costa Mesa, California (PRWEB) December 05, 2013

WCCT Global, a full service contract research organization headquartered in Southern California announced today that CEO Dr. Kenneth Kim will be presenting at the 2013 Up-to-date Topics in Global Clinical Trials Conference in Korea on December 11th. The event will be held at the Hotel Shilla in Seoul, Korea. Dr. Kim is a well-recognized expert in the area of global clinical development and his company WCCT Global is currently one of the leading full service CRO’s in the industry. WCCT Global is implementing fresh new ideas, and trends in: remote risk based monitoring, patient recruitment, and simultaneous vs. sequential global development will be among the topics covered. Dr. Kim stated, “I am pleased to be able to present where the clinical development industry is headed. With the use of technology and new clinical ideology, clinical research is becoming much more effective and leading to more efficient testing periods for new therapies.”

As global clinical development quickly evolves in areas including: regulatory, biometric, and clinical research. Staying informed with the latest methods of operation is vital to success in the industry. This conference will shed light on the potential of making global drug development more efficient, effective, and either cost neutral or less expensive than the previous traditional ways of research. Since being founded, WCCT Global has been on the forefront of setting new trends for clinical development.

WCCT Global is a multi-site, full-service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting-edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT Global has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.

For more information about WCCT Global and how they may be of service to your next clinical trial: CLICK HERE

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/12/prweb11388816.htm

Source: prweb

comments powered by Disqus